Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which dialysis method offers the best life and survival?

NCT ID NCT07781124

Knowledge-focused Sponsor: Vantive Health LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study follows adults with end-stage renal disease who are starting dialysis to compare three approaches: automated peritoneal dialysis with remote monitoring, manual peritoneal dialysis, and in-center hemodialysis. Researchers will track quality of life, social reintegration, complications, survival, and healthcare resource use over time. The goal is to see which method may offer the best balance of outcomes and costs in real-world practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dialysis modality (remote patient monitoring-automated peritoneal dialysis, manual peritoneal dialysis, or maintenance hemodialysis)
What this could lead to
If successful, this could help doctors and patients choose the dialysis method that best improves quality of life and survival while reducing healthcare costs.
What could go wrong
As an observational study, it cannot prove cause and effect, and differences between groups may be due to factors other than the dialysis method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 750 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study plans to screen Chinese patients receiving remote patient monitoring-automated peritoneal dialysis (RPM-APD), manual peritoneal dialysis (manual PD), or maintenance hemodialysis (HD). Each patient must meet all inclusion criteria and none of the exclusion criteria for this study. No exceptions are permitted under any circumstances.

Ages

18 to 79 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥ 18 years and \< 80 years. * Diagnosed with ESRD and planned to initiate RPM-APD / manual PD / HD as maintenance dialysis within 3 months after signing the ICF. * Able to continue long-term follow-up and treatment at the study site after enrollment. * Voluntarily sign the ICF and are able to complete study visits and questionnaires as required by the Investigator or have a caregiver to assist in completing study-related procedures. Exclusion Criteria: * Diagnosed with acute kidney injury (AKI). * Received dialysis therapy for more than 1 month. * History of kidney transplantation. * Presence of other severe diseases, such as malignancies with active or residual lesions despite treatment, systemic infections, decompensated liver cirrhosis, severe lactic acidosis, etc. * Patients with HIV infection or syphilis infection. * Presence of psychiatric disorders or inability to cooperate. * Pregnant or breastfeeding women, as well as women of childbearing potential unwilling to use effective contraception during the study period. * Currently participating in another interventional study or having participated in another interventional study within 1 month prior to enrollment. * Any other condition that, in the opinion of the Investigator, makes the patient unsuitable for participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease (CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease (CKD) End stage renal disease (ESRD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    20 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beijing Haidian Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100080, China

  • China-Japan Friendship Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510120, China

  • Hangzhou Hospital of Traditional Chinese Medicine

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310007, China

  • Hebei Medical University Third Hospital

    NOT_YET_RECRUITING

    Shijiazhuang, Hebei, 050051, China

  • Henan Provincial People's Hospital

    NOT_YET_RECRUITING

    Zhengzhou, Henan, 450003, China

  • Peking University First Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100034, China

  • Peking University Third Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100191, China

  • Shanghai Sixth People's Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200233, China

  • The Affiliated Hospital of Qingdao University

    NOT_YET_RECRUITING

    Qingdao, Shandong, 266555, China

  • The First Affiliated Hospital of Baotou Medical College

    NOT_YET_RECRUITING

    Baotou, Inner Mongolia, 014010, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    NOT_YET_RECRUITING

    Xi'an, Shaanxi, 710061, China

  • The Second Affiliated Hospital of Chongqing Medical University

    NOT_YET_RECRUITING

    Chongqing, Chongqing Municipality, 400010, China

  • The Second Affiliated Hospital of Harbin Medical University

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, 150001, China

  • The Second Norman Bethune Hospital of Jilin University

    NOT_YET_RECRUITING

    Changchun, Jilin, 130041, China

  • The Third Xiangya Hospital of Central South University

    NOT_YET_RECRUITING

    Changsha, Hunan, 410013, China

  • Tianjin First Central Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 300190, China

  • Wuxi People's Hospital

    NOT_YET_RECRUITING

    Wuxi, Jiangsu, 214023, China

  • Yantai Yuhuangding Hospital

    NOT_YET_RECRUITING

    Yantai, Shandong, 264000, China

  • Zhongnan Hospital of Wuhan University

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430071, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.